Morphological characteristics of severe aortic stenosis in China: Imaging corelab observations from the first Chinese transcatheter aortic valve trial

Catheterization and Cardiovascular Interventions

Volumn 85, Issue S1, 2015, Pages 752-761

  Jilaihawi, Hasan ^a   Wu, Yongjian ^b   Yang, Yuejin ^b   Xu, Liang ^b   Chen, Mao ^c   Wang, Jianan ^d   Kong, Xiangqing ^e   Zhang, Ruiyan ^f   Wang, Moyang ^b   Lv, Bin ^b   Wang, Wei ^b   Xu, Bo ^b   Makkar, Raj R ^a   Sievert, Horst ^g   Gao, Runlin ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b FUWAI HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g CardioVascular Center Clinic   (Germany)

Author keywords

aortic Stenosis; China; race; TAVR; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTICLE; CALCIFICATION; CHINA; CHINESE; CLINICAL PROTOCOL; COMPARATIVE ANATOMY; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PATHOLOGICAL ANATOMY; POPULATION RESEARCH; PROSPECTIVE STUDY; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE; AORTIC VALVE STENOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; CONGENITAL MALFORMATION; EPIDEMIOLOGY; ETHNOLOGY; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; VALVULAR HEART DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIAC CATHETERIZATION; CHINA; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84925236101     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25863     Document Type: Article

References (22)

1. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2011; 363: 1597-1607.
2. Grube E, Sinning JM, Vahanian A,. The year in cardiology 2013: Valvular heart disease (focus on catheter-based interventions). Eur Heart J 2014; 35: 490-495.
3. Jilaihawi H, Makkar RR, Kashif M, et al. A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging 2014; 15: 1324-1332.
4. Himbert D, Pontnau F, Messika-Zeitoun D, et al. Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves. Am J Cardiol 2012; 110: 877-883.
5. Hayashida K, Bouvier E, Lefévre, et al. Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis. Circ Cardiovasc Interv 2013; 6: 284-291.
6. Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013; 310: 2069-2077.
7. Bauer T, Linke A, Sievert H, et al. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the german TAVI registry). Am J Cardiol 2014; 113: 518-521.
8. Costopoulos C, Latib A, Maisano F, et al. Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves. Am J Cardiol 2014; 113: 1390-1393.
9. Wijesinghe N, Ye J, Rodés-Cabau J, et al. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis. JACC Cardiovasc Interv 2010; 3: 1122-1125.
10. O'Sullivan CJ, Windecker S,. Implications of bicuspid aortic valves for transcatheter aortic valve implantation. Circ Cardiovasc Interv 2013; 6: 204-206.
11. Roberts WC, Janning KG, Ko JM, Filardo G, Matter GJ,. Frequency of congenitally bicuspid aortic valves in patients >/=80 years of age undergoing aortic valve replacement for aortic stenosis (with or without aortic regurgitation) and implications for transcatheter aortic valve implantation. Am J Cardiol 2012; 109: 1632-1636.
12. Freeman RV, Otto CM,. Bicuspid aortic valve and aortopathy: See the first, then look at the second. JACC Cardiovasc Imaging 2013; 6: 162-164.
13. Roberts WC, Ko JM, Filardo G, et al. Valve structure and survival in septuagenarians having aortic valve replacement for aortic stenosis (+/-aortic regurgitation) with versus without coronary artery bypass grafting at a single US medical center (1993 to 2005). Am J Cardiol 2007; 100: 1157-1165.
14. Michelena HI, Khanna AD, Mahoney D, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011; 306: 1104-1112.
15. Masuda EM, Caps MT, Singh N, et al. Effect of ethnicity on access and device complications during endovascular aneurysm repair. J Vasc Surg 2004; 40: 24-29.
16. Nasir K, Katz R, Takasu J, et al. Ethnic differences between extra-coronary measures on cardiac computed tomography: Multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 2008; 198: 104-114.
17. Fang J, Madhavan S, Alderman MH,. Cardiovascular mortality of Chinese in New York city. J Urban Health 1999; 76: 51-61.
18. Schultz C, Rossi A, van Mieghem N, et al. Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the medtronic CoreValve prosthesis. EuroIntervention 2011; 7: 564-572.
19. John D, Buellesfeld L, Yuecel S, et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010; 3: 233-243.
20. Latsios G, Gerckens U, Buellesfeld L, et al. " Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 2010; 76: 431-439.
21. Manoharan G, Spence MS, Rodés-Cabau J, Webb JG,. St Jude Medical Portico valve. EuroIntervention 2012; 8 Suppl Q: Q97-Q101.
22. Piazza N, Martucci G, Lachapelle K, et al. First-in-human experience with the Medtronic CoreValve Evolut R. EuroIntervention 2014; 9: 1260-1263.